Form 4 for KPRX KIORA PHARMACEUTICALS INC
Accepted 2021-09-03 00:00:00 ET · period of report 2021-09-02 · accession 0001104659-21-112937 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-03 | 2021-09-02 | KPRX | Mann Brenda | VP of Research, Development | F - Tax | $1.81 | -61 | 15.3K | -0.4% | -$110.41 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-02 | F | D | 61 | $1.81 | 15,260 | D | — | — |